Vertex Pharmaceuticals Inc (VRTX) Dividend History

Company News

• CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

  CRISPR Therapeutics announced positive Phase 1 clinical data for CTX310, a gene therapy targeting ANGPTL3, showing significant reductions in triglycerides and LDL cholesterol with a well-tolerated safety profile. The company is advancing multiple cardiovascular disease programs and expects to present complete data in late 2025.

  GlobeNewswire Inc.

  Featured Companies: CRSP
• 2 Growth Stocks to Buy and Hold for 10 Years

  Shopify and Vertex Pharmaceuticals are two stocks that could deliver superior returns over the next decade. Shopify is a leader in the fast-growing e-commerce market with a strong moat, while Vertex Pharmaceuticals is the only game in town for patients with cystic fibrosis and has a promising pipeline of new products.

  The Motley Fool

  Featured Companies: SHOP
• HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'

  The Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals' proposed fertility services program, claiming it would breach anti-kickback laws by incentivizing patients to choose Vertex's gene therapy over competitors.

  Benzinga
• Top Research Reports for NVIDIA, Home Depot & Vertex Pharmaceuticals

  The article discusses the latest research reports on 16 major stocks, including NVIDIA, Home Depot, Vertex Pharmaceuticals, and a micro-cap company Moving iMage Technologies. It highlights the key drivers and challenges for these companies.

  Zacks Investment Research

  Featured Companies: HD MITQ NVDA
• Abm Industries executive sells over $100k in company stock By Investing.com - Investing.com

  Vertex Pharmaceuticals' Executive Vice President and Chief Medical Officer, Carmen Bozic, sold $1.1 million worth of the company's stock. The sale was part of a prearranged trading plan, and Bozic still holds 27,819 shares in the company.

  Investing.com